1·Monoamine oxidase a (MAOA) is an enzyme that breaks down neurotransmitters (signaling chemicals) in the brain.
单胺氧化酶是一种能分解脑部神经传导物质(信号化学物质)的酶。
2·The genes for which most placebo-related SNP evidence exists encode enzymes called catechol-O-methyltransferase and monoamine oxidase.
大部分与安慰剂相关的SNP证据表明，基因编码的酶被称为儿茶酚- o -甲基转移酶和单胺氧化酶。
3·Purpose To study the effects of trihexyphenidyl (THP) on levels of monoamine neurotransmitters in the cerebral cortex after subarachnoid hemorrhage (SAH).
目的探讨苯海索（THP）对蛛网膜下腔出血（SAH）后脑皮质内单胺递质水平的影响。
4·The compounds of the invention are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters.
发现本发明化合物是烟碱样乙酰胆碱受体的胆碱能配体和单胺受体和转运蛋白的调节剂。
5·National Center for Drug Screening confirmed that the bioactive fraction was reliably inhibitory to monoamine oxidase and possessed potential anti-ageing effect.
该活性片段经国家新药筛选中心确证有抑制单胺氧化酶的效果，具有潜在的抗衰老作用。